Low rates of mother-to-child transmission of HIV-1 and risk factors for infection in Spain: 2000-2007

Pediatric Infectious Disease Journal

Volumn 31, Issue 10, 2012, Pages 1053-1058

  Prieto, Luis Manuel ^a   González Tomé, María Isabel ^b   Muñoz, Eloy ^b   Fernández Ibieta, María ^a   Soto, Beatriz ^a   Del Rosal, Teresa ^c   Cuadrado, Irene ^a   Navarro, María Luisa ^d   Roa, Miguel Ángel ^e   Beceiro, José ^f   De José, María Isabel ^c   Santos, María José ^g   Lora, David ^b   Ramos, José Tomás ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL DE MÓSTOLES   (Spain)

^f HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^g HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

HIV infection; mother to child transmission; pregnancy; vertical transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; CESAREAN SECTION; CHEMOPROPHYLAXIS; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL CARE; NEWBORN; NEWBORN INFECTION; OBSERVATIONAL STUDY; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SPAIN; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84866600869     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826fe968     Document Type: Review

References (25)

1. Joint United Nations Programme on HIV/AIDS, UNAIDS Outlook Report, UNAIDS, Geneva, July 2010. Available at: http://www.unaids.org/en/media/unaids/ contentassets/documents/unaidspublication. Accessed September 14, 2011.
2. Kourtis A P, Lee FK, Abrams EJ, et al. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis. 2006;6: 726-732.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodefciency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.
4. The European Mode of Delivery Collaboration. Elective caesarian-section vs. vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353:1035-1039.
5. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodefciency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med. 1999;341:385-393.
6. Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50:585-596.
7. Cooper ER, Charurat M, Mofenson L, et al; Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defc Syndr. 2002;29:484-494.
8. de Ruiter A, Mercey D, Anderson J, et al. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med. 2008;9:452-502.
9. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Sep. 14, 2011;1-207. Available at: http://aidsinfo.nih.gov/contentfles/PerinatalGL. pdf. Accessed September 14, 2011.
10. Recomendaciones de la Secretaría del Plan Nacional sobre el Sida (SPNS), el Grupo de Estudio de Sida (GeSida/SEIMC), la Sociedad Española de Ginecología y Obstetricia (SEGO) y la Asociación Española de Pediatría (AEP) para el seguimiento de la Infección VIH con relación a la reproduc-ción, el embarazo y la prevención de la transmisión vertical. June 2007. Available at: www.msc.es. Accessed September 11, 2011.
11. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
12. Goetghebuer T, Haelterman E, Marvillet I, et al. Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Eur J Pediatr. 2009;168:79-85.
13. von Linstow ML, Rosenfeldt V, Lebech AM, et al. Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008. HIV Med. 2010;11:448-456.
14. Warszawski J, Tubiana R, Le Chenadec J, et al ANRS French Perinatal Cohort. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22:289-299.
15. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;8:973-981.
16. Ministerio de Trabajo e Inmigración. Secretaria de Estado de Inmigracion y Emigracion. Anuario estadístico de inmigración 2007. Available at: http://extranjeros.mtas.es/es/InformacionEstadistica/Anuarios/ Anuario2007.htm. Accessed September 11, 2011.
17. Centro Nacional de Epidemiología. Valoración de los nuevos diagnósticos de VIH en España a partir de los sistemas de notifcación de casos de las CCAA, periodo 2003-2007. Madrid: Instituto de Salud Carlos III; 2008. Available at: http://www.isciii.es/htdocs/pdf/nuevos- diagnosticos-ccaa.pdf. Accessed September 11, 2011.
18. Castilla J, Guevara M. [Immigration and HIV in Spain]. Enferm Infecc Microbiol Clin. 2009;27:375-376.
19. European Centre for the Epidemiological Monitoring of AIDS. HIV/AIDS Surveillance in Europe: Mid-year report 2007. No. 76. 2007. Available at: http://www.eurohiv.org. Accessed September 11, 2011.
20. Peters V, Liu KL, Dominguez K, et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort. Pediatrics. 2003;111(5 pt 2): 1186-1191.
21. Caro-Murillo AM, Gutiérrez F, Manuel Ramos J, et al; CoRIS. [HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)]. Enferm Infecc Microbiol Clin. 2009;27:380-388.
22. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1996;335:1621-1629.
23. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS. 2007;21:501-507.
24. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-981.
25. European Collaborative Study. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis. 2007;44:1647-1656.